Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage D0 Prostate Cancer”

9 trials

Showing 9 of 9 results

Testing effectiveness (Phase 2)Study completedNCT02362464
What this trial is testing

Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139

Who this might be right for
Prostatic NeoplasmsNeoplasms of ProstateProstate Cancer+2 more
National Cancer Institute (NCI) 14
Early research (Phase 1)Study completedNCT00582140
What this trial is testing

Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 22
Testing effectiveness (Phase 2)UnknownNCT00514072
What this trial is testing

Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer

Who this might be right for
Prostate Cancer
Kael-GemVax Co., Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT00454571
What this trial is testing

Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Recurrent Prostate Cancer
National Cancer Institute (NCI) 37
Early research (Phase 1)Ended earlyNCT00702923
What this trial is testing

CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 12
Testing effectiveness (Phase 2)Ended earlyNCT02362451
What this trial is testing

Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate Cancer
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT00176605
What this trial is testing

Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 15
Large-scale testing (Phase 3)Study completedNCT00004635
What this trial is testing

Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 159
Early research (Phase 1)Study completedNCT00972309
What this trial is testing

A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer

Who this might be right for
Prostate Specific AntigensProstate Neoplasms
National Cancer Institute (NCI) 41

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation